JANUARY
27
Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
READ MORE >>JANUARY
20
Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI
READ MORE >>JANUARY
4
Infinity Provides Key 2012 Goals and Financial Guidance
READ MORE >>